Brief: Mabion Signs Quality Agreement With Novavax
19/11/2021 16:53
Nov 19 (Reuters) - Mabion SA MABP.WA :
* SIGNS QUALITY AGREEMENT WITH NOVAVAX
* AGREEMENT COVERS TECHNICAL AND REGULATORY ARRANGEMENTS
REGARDING
PRODUCTION OF ANTIGEN OF VACCINE CANDIDATE FOR COVID-19 UNDER
NAME NUVAXOVID™
Source text for Eikon: ID:nEM1L9VPha
Further company coverage: MABP.WA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Mabion SA
See all newsBrief: Mabion Signs Annex To Extend Production Agreement With Novavax To End of 2029
Brief: Mabion Signs Deal With Oddifact Sas On Preparing Mabioncd20 For FDA Consultation
Brief: Mabion Q1 Net Loss 9.7 Million Zlotys
Brief: Mabion Signs LoI With Oddifact On Use Of MabionCD20 Drug For Orphan Diseases
Brief: Mabion FY Net Loss 62.6 Million Zlotys